{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:12:41Z","timestamp":1788901961640,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017037","name":"Cepheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cca.2026.121169","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:32:21Z","timestamp":1781278341000},"page":"121169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Xpert\u00ae bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial"],"prefix":"10.1016","volume":"592","author":[{"given":"Mohamed","family":"Trabelssi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Daures","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Perriard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Poinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121169_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2026.121169_bb0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage ta-T1 urothelial bladder Cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0020","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1002\/cncr.25310","article-title":"Delays in diagnosis and bladder cancer mortality","volume":"116","author":"Hollenbeck","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121169_bb0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.purol.2022.08.006","article-title":"French AFU Cancer committee guidelines - update 2022-2024: non-muscle-invasive bladder cancer (NMIBC)","volume":"32","author":"Neuzillet","year":"2022","journal-title":"Prog. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder Cancer (ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-022-04253-3","article-title":"Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review","author":"Soorojebally","year":"2023","journal-title":"World J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0055","article-title":"Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review","volume":"14","author":"KBCA","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121169_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081283","article-title":"Novel urinary biomarkers for the detection of bladder cancer","volume":"17","author":"Oyaert","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2026.121169_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","article-title":"Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer","volume":"75","author":"Valenberg","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0075","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00345-021-03629-1","article-title":"Assessment of Xpert bladder Cancer monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up","volume":"39","author":"Cancel-Tassin","year":"2021","journal-title":"World J. Urol."},{"issue":"3","key":"10.1016\/j.cca.2026.121169_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.juro.2017.09.141","article-title":"Development of a 90-minute integrated noninvasive urinary assay for bladder Cancer detection","volume":"199","author":"Wallace","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0085","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.eururo.2011.05.053","article-title":"Urine markers for detection and surveillance of non-muscle-invasive bladder cancer","volume":"60","author":"Tilki","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0095","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","article-title":"An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/diseases12090219","article-title":"The simultaneous use of bladder Epicheck\u00ae and urinary cytology can improve the sensitivity and specificity of diagnostic follow-up of urothelial lesions: up-to-date data from a multi-institutional cohort","volume":"12","author":"Pepe","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.cca.2026.121169_bb0105","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s11136-016-1264-z","article-title":"Anxiety and depression analyses of patients undergoing diagnostic cystoscopy","volume":"25","author":"Seklehner","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.cca.2026.121169_bb0110","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00345-018-2550-x","article-title":"Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories","volume":"37","author":"Mossanen","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.cca.2026.121169_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bju.14019","article-title":"Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance","volume":"121","author":"Pichler","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.cca.2026.121169_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jclinpath-2018-205393","article-title":"Diagnostic predictive value of Xpert bladder cancer monitor in the follow-up of patients affected by non-muscle invasive bladder cancer","volume":"72","author":"C","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2026.121169_bb0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.22246","article-title":"Comparison of 2 new realtime polymerase chain reaction-based urinary markers in the follow-up of patients with nonmuscle-invasive bladder cancer","volume":"128","author":"Trenti","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.cca.2026.121169_bb0130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00345-019-03002-3","article-title":"Clinical performance of Xpert bladder cancer (BC) monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the bladder cancer Italian active surveillance (BIAS) project","volume":"38","author":"Hurle","year":"2020","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.cca.2026.121169_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euf.2016.06.011","article-title":"Molecular characterization of bladder Cancer in smokers versus nonsmokers","volume":"4","author":"Joshi","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.cca.2026.121169_bb0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/bju.15418","article-title":"Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert\u00ae bladder Cancer monitor) for surveillance in patients with non-muscle-invasive bladder cancer","volume":"128","author":"Cowan","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.cca.2026.121169_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512489","article-title":"Bladder Epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121169_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/diseases12090219","article-title":"The simultaneous use of Bladder Epicheck\u00ae and urinary cytology can improve the sensitivity and specificity of diagnostic follow-up of urothelial lesions: up-to-date data from a multi-institutional cohort","volume":"12","author":"Pepe","year":"2024","journal-title":"Diseases"},{"issue":"4","key":"10.1016\/j.cca.2026.121169_bb0155","first-page":"278","article-title":"North American study and meta-analysis evaluating performance of Bladder EpiCheck\u00ae, a FDA cleared test, in non-muscle invasive bladder cancer recurrence. Bladder","volume":"10","author":"Fleshner","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121169_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euo.2020.09.001","article-title":"Validation of an mRNA-based urine test for the detection of bladder Cancer in patients with haematuria","volume":"4","author":"Valenberg","year":"2021","journal-title":"Eur Urol Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121169_bb0165","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.urolonc.2020.06.018","article-title":"The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: effective tool or useless expence?","volume":"39","author":"Pierconti","year":"2021","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121169_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2025.03.018","article-title":"Use of the Xpert bladder Cancer monitor urinary biomarker test for guiding cystoscopy in high-grade non-muscle-invasive bladder Cancer: results from the randomized controlled DaBlaCa-15 trial","volume":"88","author":"Dreyer","year":"2025","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.cca.2026.121169_bb0175","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.euo.2025.04.020","article-title":"Results of the prospective randomized UroFollow trial comparing marker-guided versus cystoscopy-based surveillance in patients with low\/intermediate-risk bladder cancer","volume":"8","author":"Schmitz-Dr\u00e4ger","year":"2025","journal-title":"Eur. Urol. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2026.121169_bb0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur. Urol. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:50:54Z","timestamp":1788900654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":36,"alternative-id":["S0009898126003517"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121169","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xpert\u00ae bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121169"}}